Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ENTA

Enanta Pharmaceuticals Inc

May 14 • 04:00PM ET

13.81

0.00 0.00 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: AVIR ABUS INO BNTC OCGN

| Held by: VTI IWM VXF IWN IBB SCHA VTWO DWAS VFMO IWC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.59	Insider Own	5.09%	Shs Outstand	29.06M	Perf Week	-8.48%
Market Cap	401.57M	Forward P/E	-	EPS next Y	-1.86	Insider Trans	-0.86%	Shs Float	27.54M	Perf Month	-5.09%
Enterprise Value	424.42M	PEG	-	EPS next Q	-0.46	Inst Own	90.90%	Short Float	7.83%	Perf Quarter	-0.22%
Income	-61.98M	P/S	5.80	EPS this Y	41.05%	Inst Trans	15.70%	Short Ratio	12.92	Perf Half Y	14.70%
Sales	69.21M	P/B	3.44	EPS next Y	17.98%	ROA	-19.44%	Short Interest	2.16M	Perf YTD	-12.43%
Book/sh	4.01	P/C	2.45	EPS next 5Y	17.16%	ROE	-59.00%	52W High	17.15 -19.48%	Perf Year	166.60%
Cash/sh	5.63	P/FCF	-	EPS past 3/5Y	13.40% -16.17%	ROIC	-23.13%	52W Low	5.04 174.01%	Perf 3Y	-45.48%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-8.82% -11.81%	Gross Margin	92.87%	Volatility	6.72% 5.62%	Perf 5Y	-73.22%
Dividend TTM	-	EV/Sales	6.13	EPS Y/Y TTM	42.85%	Oper. Margin	-87.24%	ATR (14)	0.83	Perf 10Y	-43.79%
Dividend Ex-Date	-	Quick Ratio	3.84	Sales Y/Y TTM	7.37%	Profit Margin	-89.56%	RSI (14)	45.95	Recom	1.38
Dividend Gr. 3/5Y	- -	Current Ratio	3.84	EPS Q/Q	57.49%	SMA20	-2.44%	Beta	1.00	Target Price	20.62
Payout	-	Debt/Eq	1.60	Sales Q/Q	14.96%	SMA50	1.33%	Rel Volume	0.00	Prev Close	13.81
Employees	120	LT Debt/Eq	1.30	Earnings	May 11 AMC	SMA200	13.75%	Avg Volume	166.77K	Price	13.81
IPO	Mar 21, 2013	Option/Short	Yes / Yes	EPS/Sales Surpr.	7.65% 0.77%	Trades		Volume	0	Change	0.00%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)